Octaplex

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor VII, Protein S, Human Coagulation Factor X, the active ingredient in Octaplex, is a complex coagulation factor concentrate presented as a sterile intravenous solution for therapeutic use. It is employed in the management of bleeding disorders and peri‑operative hemostasis in patients with specific factor deficiencies.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Octaplex is used to replace multiple deficient coagulation factors in patients with inherited or acquired bleeding disorders. - Hemophilia A and B with inhibitors: provides temporary hemostasis while awaiting specific factor replacement. - Congenital protein C deficiency: restores protein C activity to reduce thrombotic risk. - Congenital protein S deficiency: supplies protein S to aid regulation of coagulation. - Peri‑operative management of major surgery: supports hemostasis in patients with multiple factor deficiencies. - Acquired coagulopathy during liver‑transplant or massive trauma: contributes to balanced coagulation restoration.

Adverse reactions to Octaplex are generally related to its protein nature and the intravenous route.

Common Side Effects: - Fever or chills - Mild headache - Nausea or vomiting - Transient hypotension - Local infusion site erythema - Mild allergic skin rash

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reaction - Thromboembolic events (deep‑vein thrombosis, pulmonary embolism) - Disseminated intravascular coagulation (DIC) - Hemolysis or renal impairment - Development of neutralising antibodies against the infused factors - Severe sepsis from contaminated product

Octaplex should be administered under close clinical supervision with attention to patient‑specific risk factors. - Prior exposure assessment: review the patient history for previous reactions to plasma‑derived products. - Thrombotic risk evaluation: assess the patient for underlying pro‑thrombotic conditions. - Monitoring: conduct regular laboratory tests for coagulation parameters and renal function. - Pregnancy and liver disease :   - Store at 2-8°C: keep refrigerated ; protect against light and avoid freezing .

OctOct  

Major  t  t

   t  t

t  t

t ",